Seven dogs histologically diagnosed with OMM and two dogs with undifferentiated sarcoma were enrolled in the pilot clinical trial, after the confirmation of PD-L1 expression in the primary cancers by immunohistochemistry (Supplementary Fig. S3). Here, CD274 is linked to cancer.